United States===Centers for Medicare & Medicaid Services

The United States===Centers for Medicare & Medicaid Services (CMS) cancelled the Making Care Primary program, citing it was not on track to meet its savings goal. This decision has led to skepticism among doctors and concerns about the future of primary care funding. CMS is launching a new program, Long-term Enhanced ACO Design (LEAD), which will direct funding to healthcare organizations rather than directly to primary care doctors.

The United States===Centers for Medicare & Medicaid Services is the federal agency implementing the funding halt and setting the conditions for United States===Minnesota to regain its Medicaid payments. It is also taking action to crack down on Medicare fraud, including blocking new Medicare enrollments for certain suppliers.

The Centers for Medicare and Medicaid Services (CMS) is leading the fraud probe into New York's Medicaid program and has already halted payments to United States===Minnesota. CMS is demanding corrective actions and transparency from these states, indicating a more aggressive stance on oversight and fraud prevention in state-run healthcare programs.

The Centers for Medicare & Medicaid Services (CMS) made a significant error in the figures used to justify a fraud probe into New York's Medicaid program. CMS later acknowledged the mistake and stated it is committed to refining its methodology and working with New York to validate data.

The United States===Centers for Medicare & Medicaid Services is being challenged in federal court over its Substance Access Beneficiary Engagement Incentive (BEI) program. Plaintiffs argue that CMS implemented the program without proper rulemaking and exceeded its authority, creating a federally supported pathway for non-FDA-approved cannabinoid products.